abstract |
FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to compound presented by Formula n n n n or Formula , n wherein A and B optionally represent CH 2 , CO; D represent S; the values R 1 , R 2 , R 4 , R 4 are specified in cl. 1 of the patent claim, as well as to their pharmacologically acceptable salts or hydrates and methods for preparing them. n EFFECT: compounds are able to inhibit TNF-α recovering cells. n 19 cl, 71 ex |